With over 0.11 million First Eagle Alternative Capital BDC Inc. (FCRD) shares trading Tuesday and a closing price of $4.56 on the day, the dollar volume was approximately $0.51 million. The shares have shown a positive half year performance of 33.72% and its price on 01/24/23 gained nearly 1.11%. Currently, there are 29.92M common shares owned by the public and among those 29.64M shares have been available to trade.
An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 2 analysts who have offered their price forecasts for FCRD have a consensus price objective of $4.50. The analysts have set the share’s price value over the next 12 months at a high of $4.50 and a low of $4.50. The average price target is -1.33% below its recent price level and a downside to the estimated low will see the stock lose -1.33% over that period. But a downside of -1.33% will see the stock hit the forecast high price target while median target price for the stock is $4.50.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The top 3 mutual fund holders in First Eagle Alternative Capital BDC Inc. are SEB SICAV 2 – Listed Private Equi, RiverNorth Opportunities Fund Inc, and RiverNorth/DoubleLine Strategic O. SEB SICAV 2 – Listed Private Equi owns 0.56 million shares of the company’s stock, all valued at over $2.38 million. RiverNorth Opportunities Fund Inc sold -0.57 million shares to see its total holdings shrink to 0.33 million shares valued at over $1.43 million and representing 1.12% of the shares outstanding. RiverNorth/DoubleLine Strategic O now owns shares totaling to 0.72% of the shares outstanding.
Shares of First Eagle Alternative Capital BDC Inc. (NASDAQ: FCRD) opened at $4.53, up $0.02 from a prior closing price of $4.51. However, the script later moved the day high at 4.6000, up 1.11%. The company’s stock has a 5-day price change of 0.44% and 17.22% over the past three months. FCRD shares are trading 7.04% year to date (YTD), with the 12-month market performance up to 3.17% higher. It has a 12-month low price of $2.74 and touched a high of $4.58 over the same period. FCRD has an average intraday trading volume of 98.88K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 4.29%, 5.41%, and 19.68% respectively.
Institutional ownership of First Eagle Alternative Capital BDC Inc. (NASDAQ: FCRD) shares accounts for 48.00% of the company’s 29.92M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.
It has a market capitalization of $135.89M and a beta (3y monthly) value of 1.52. The earnings-per-share (ttm) stands at -$0.96. The company has a debt-to-equity ratio at 1.43. Price movements for the stock have been influenced by the stock’s volatility, which stands at 1.94% over the week and 1.95% over the month.
Analysts forecast that First Eagle Alternative Capital BDC Inc. (FCRD) will achieve an EPS of $0.11 for the current quarter, $0.12 for the next quarter and $0.47 for 2023. The lowest estimate earnings-per-share for the quarter is $0.11 while analysts give the company a high EPS estimate of $0.12. Comparatively, EPS for the current quarter was $0.11 a year ago. Earnings per share for the fiscal year are expected to increase by 150.30%, and 14.13% over the next financial year. EPS should grow at an annualized rate of 5.00% over the next five years, compared to 2.60% over the past 5-year period.
If you are looking to buy this stock, then you may note that the average analyst recommendation by 2 brokerage firm advisors rate First Eagle Alternative Capital BDC Inc. (FCRD) as a “Hold” at a consensus score of 3.00. Specifically, 0 Wall Street analysts polled rate the stock as a buy, while 2 of the 2 advise that investors “hold,” and 0 rated it as a “Sell.”
Looking at the support for the FCRD, a number of firms have released research notes about the stock. Oppenheimer stated their Perform rating for the stock in a research note on September 20, 2021, with the firm’s price target at $5.